Rapid urbanization, particularly in developing countries, has given rise to sedentary lifestyles, leading to high consumption of tobacco and smoking.

Global Respiratory Diagnostics Market by Product and Service Type (Instruments and Services, Assays and Reagents, Services and Software), Test Type (Mechanical Tests, Obstructive Sleep Apnoea (OSA) Diagnostic Tests, Imaging Tests, Traditional Diagnostic Tests, Molecular Diagnostic Tests & Others), Disease (Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease (COPD), Lung Cancer & Others), Key Players and Region – Industry Outlook to 2028.

What is the size of the respiratory diagnostics market?

According to the latest report by IMARC Group, the global respiratory diagnostics market reached US$ 7.5 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 11.7 Billion by 2028, exhibiting a growth rate (CAGR) of 7.65% during 2023-2028.

Respiratory diagnostic, also known as respiratory or lung examination, is the clinical process carried for assessing lung functioning and other related issues. It is generally practiced when the patient experiences chest pain, cough and irritation in the respiratory tract, or irregular breathing patterns, among other medical conditions. Respiratory diagnostic procedures include chest X-ray, oximetry, sniff nasal inspiratory pressure (SNIP), CT scan, and spirometry. Advanced diagnostic methods improve patient management leading to reduced antibiotics dosage, shorter hospital stays, and minimized health risks.

Request for a sample copy of this report: www.imarcgroup.com/respiratory-diagnostics-market/requestsample

Respiratory Diagnostics Market Trends:

Rapid urbanization, particularly in developing countries, has given rise to sedentary lifestyles, leading to high consumption of tobacco and smoking. Also, the increasing air pollution in countries, like India and China, has accelerated the prevalence of chronic diseases, such as asthma, lung cancer, pulmonary fibrosis, and bronchitis. These factors, coupled with the growing geriatric population, have catalyzed the demand for respiratory diagnostic devices in private hospitals and clinics. Additionally, various technological advancements, such as the introduction of artificial intelligence (AI)-based advanced molecular diagnostic tests, has positively influenced the efficiency of respiratory diagnostics.

Ask An Analyst – www.imarcgroup.com/request?type=report&id=1620&flag=C

Competitive Landscape:

Some of the top respiratory diagnostics manufacturers are:

  • Philips Healthcare,
  • Abbott Laboratories,
  • Biomerieux,
  • Becton Dickinson,
  • Thermo Fisher Scientific Inc.,
  • Alere Inc.,
  • Seegene Inc.,
  • 3M,
  • Bio-Rad Laboratories,
  • SDI Diagnostics

Report Segmentation:

The report has been segmented the market into following categories:

Breakup by Product and Service Type:

  • Instruments and Services
  • Assays and Reagents
  • Services and Software

Breakup by Test Type:

  • Mechanical Tests
  • Obstructive Sleep Apnoea (OSA) Diagnostic Tests
  • Imaging Tests
  • Traditional Diagnostic Tests
  • Molecular Diagnostic Tests
  • Others

Breakup by Disease:

  • Tuberculosis
  • Asthma
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Lung Cancer
  • Others

Breakup by End-User:

  • Hospitals
  • Clinics
  • Reference and Clinical Laboratories
  • Others

Breakup by Region:

  • North America
  • Europe
  • Asia Pacific
  • Middle East and Africa
  • Latin America

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us


134 N 4th St. Brooklyn, NY 11249, USA

USA: +1-631-791-1145 | Asia: +91-120-433-0800

Email: [email protected]

Follow us on Twitter: @imarcglobal

LinkedIn: www.linkedin.com/company/imarc-group/mycompany

Source link